Title: Oral delivery of a functional algal-expressed TGF-β mimic halts colitis in a murine DSS model

Journal Article · · Journal of Biotechnology
 [1]; ORCiD logo [2];  [3];  [3]; ORCiD logo [3]; ORCiD logo [3];  [4]; ORCiD logo [4];  [2];  [3];  [2]
  1. Univ. of Glasgow, Scotland (United Kingdom). Wellcome Centre for Integrative Parasitology, Institute of Infection, Immunity and Inflammation; University of California, San Diego
  2. Univ. of California, San Diego, CA (United States). California Center for Algae Biotechnology, Division of Biological Sciences
  3. Univ. of Glasgow, Scotland (United Kingdom). Wellcome Centre for Integrative Parasitology, Institute of Infection, Immunity and Inflammation
  4. Univ. of Sheffield (United Kingdom). Bioanalytical Facility, Dept. Chemical and Biological Engineering

Inflammatory bowel disease (IBD) is a set of immunological disorders which can generate chronic pain and fatigue associated with the inflammatory symptoms. The treatment of IBD remains a significant hurdle with current therapies being only partially effective or having significant side effects, suggesting that new therapies that elicit different modes of action and delivery strategies are required. TGM1 is a TGF-β mimic that was discovered from the intestinal helminth parasite Heligmosomoides polygyrus and is thought to be produced by the parasite to suppress the intestinal inflammation response to help evade host immunity, making it an ideal candidate to be developed as a novel anti-inflammatory bio-therapeutic. Here we utilized the expression system of the edible green algae Chlamydomonas reinhardtii in order to recombinantly produce active TGM1 in a form that could be ingested. C. reinhardtii robustly expressed TGM1, and the resultant recombinant protein is biologically active as measured by regulatory T cell induction. When delivered orally to mice, the algal expressed TGM1 is able to ameliorate weight loss, lymphadenopathy, and disease symptoms in a mouse model of DSS-induced colitis, demonstrating the potential of this biologic as a novel treatment of IBD.

Research Organization:
Univ. of California, San Diego, CA (United States)
Sponsoring Organization:
USDOE Office of Energy Efficiency and Renewable Energy (EERE), Transportation Office. Bioenergy Technologies Office
Grant/Contract Number:
EE0008246
OSTI ID:
1822261
Journal Information:
Journal of Biotechnology, Journal Name: Journal of Biotechnology Vol. 340; ISSN 0168-1656
Publisher:
ElsevierCopyright Statement
Country of Publication:
United States
Language:
English

References (72)

Dextran Sulfate Sodium (DSS)‐Induced Colitis in Mice journal February 2014
Recombinant human interleukin 10 for induction of remission in Crohn's disease journal November 2010
Synthesis and assembly of a full-length human monoclonal antibody in algal chloroplasts journal January 2009
Production of recombinant proteins in microalgae at pilot greenhouse scale: Recombinant Protein Production in Algae journal September 2014
Treatment of colitis with a commensal gut bacterium engineered to secrete human tgf-β1 under the control of dietary xylan journal January 2011
Heligmosomoides Polygyrus Abrogates Antigen-Specific Gut Injury in a Murine Model of Inflammatory Bowel Disease journal January 2012
TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota journal May 2017
A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice journal March 1990
Crohn's disease journal November 2012
Development of a dot-blot assay for screening monoclonal antibodies to low-molecular-mass drugs journal December 2010
Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease journal January 2020
A Phase I Trial With Transgenic Bacteria Expressing Interleukin-10 in Crohn’s Disease journal June 2006
TNFα blockade in human diseases: Mechanisms and future directions journal February 2008
Interleukin-13 Is the Key Effector Th2 Cytokine in Ulcerative Colitis That Affects Epithelial Tight Junctions, Apoptosis, and Cell Restitution journal August 2005
Translatability of helminth therapy in inflammatory bowel diseases journal March 2013
TGF-β mimic proteins form an extended gene family in the murine parasite Heligmosomoides polygyrus journal April 2018
Regulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3 journal March 2005
TGFβ in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T Cells journal February 2006
Th17 Cells Express Interleukin-10 Receptor and Are Controlled by Foxp3− and Foxp3+ Regulatory CD4+ T Cells in an Interleukin-10-Dependent Manner journal April 2011
Modulation of Host Immunity by Helminths: The Expanding Repertoire of Parasite Effector Molecules journal November 2018
Effects of the microalgae Chlamydomonas on gastrointestinal health journal February 2020
Isolation and functional characterisation of lamina propria leukocytes from helminth-infected, murine small intestine journal February 2020
Balancing acts: the role of TGF-β in the mucosal immune system journal November 2011
The Untapped Pharmacopeic Potential of Helminths journal October 2018
Parasitic helminths: a pharmacopeia of anti-inflammatory molecules journal December 2008
Uncorking the biomanufacturing bottleneck journal August 2002
Chemically induced mouse models of intestinal inflammation journal March 2007
Immunopathogenesis of IBD: current state of the art journal December 2015
Cytokines in inflammatory bowel disease journal April 2014
Regulatory T cells control the dynamic and site-specific polarization of total CD4 T cells following Salmonella infection journal May 2020
Contextual determinants of TGFβ action in development, immunity and cancer journal April 2018
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease journal December 2000
Trichuris suis therapy for active ulcerative colitis: A randomized controlled trial journal April 2005
Peripheral and Intestinal Regulatory CD4+CD25high T Cells in Inflammatory Bowel Disease journal June 2005
Characteristics of Intestinal Dendritic Cells in Inflammatory Bowel Diseases journal July 2005
Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn’s Disease journal March 2015
Ulcerative Colitis journal November 2011
Production of unique immunotoxin cancer therapeutics in algal chloroplasts journal December 2012
Cytochrome f and plastocyanin: their sequence in the photosynthetic electron transport chain of Chlamydomonas reinhardi. journal December 1965
Exploring the N -glycosylation Pathway in Chlamydomonas reinhardtii Unravels Novel Complex Structures journal August 2013
The Transcription Factor T-bet Regulates Mucosal T Cell Activation in Experimental Colitis and Crohn's Disease journal May 2002
Biology and therapeutic potential of interleukin-10 journal October 2019
Gut Inflammation in Mice Triggers Proliferation and Function of Mucosal Foxp3 + Regulatory T Cells but Impairs Their Conversion from CD4 + T Cells journal June 2016
Immunoreactivity in mammals of two typical plant glyco-epitopes, core alpha(1,3)-fucose and core xylose journal December 2002
Interleukin-27 Is a Potential Rescue Therapy for Acute Severe Colitis Through Interleukin-10–Dependent, T-Cell–Independent Attenuation of Colonic Mucosal Innate Immune Responses journal January 2017
Induction of stable human FOXP3 + Tregs by a parasite‐derived TGF‐β mimic journal June 2021
The parasite cytokine mimic Hp ‐TGM potently replicates the regulatory effects of TGF‐β on murine CD4 + T cells journal July 2021
Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice journal February 1997
Expression of CD4+ forkhead box P3 (FOXP3)+ regulatory T cells in inflammatory bowel disease: CD4+ FOXP3+ regulatory T cells in IBD journal July 2011
Algal chloroplast produced camelid V H H antitoxins are capable of neutralizing botulinum neurotoxin journal September 2014
Expanding the spectral palette of fluorescent proteins for the green microalga Chlamydomonas reinhardtii journal April 2013
Multiple xylosyltransferases heterogeneously xylosylate protein N ‐linked glycans in Chlamydomonas reinhardtii journal January 2020
Treatment of Murine Colitis by Lactococcus lactis Secreting Interleukin-10 journal August 2000
Alga-Produced Cholera Toxin-Pfs25 Fusion Proteins as Oral Vaccines journal April 2013
Parasite Proximity Drives the Expansion of Regulatory T Cells in Peyer's Patches following Intestinal Helminth Infection journal September 2015
Alga-Produced Malaria Transmission-Blocking Vaccine Candidate Pfs25 Formulated with a Human Use-Compatible Potent Adjuvant Induces High-Affinity Antibodies That Block Plasmodium falciparum Infection of Mosquitoes journal May 2015
A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon   antibody, in patients with moderate to severe Crohn's disease journal September 2005
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial journal May 2012
Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study journal October 2014
Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study journal January 2018
Inflammatory Bowel Disease journal March 2010
Helminths in the gastrointestinal tract as modulators of immunity and pathology journal June 2017
Acute small intestinal inflammation results in persistent lymphatic alterations journal March 2018
Highly sensitive and specific bioassay for measuring bioactive TGF-β journal March 2006
Robust Expression and Secretion of Xylanase1 in Chlamydomonas reinhardtii by Fusion to a Selection Gene and Processing with the FMDV 2A Peptide journal August 2012
The Peyer’s Patch Mononuclear Phagocyte System at Steady State and during Infection journal October 2017
Novel Insights Into N-Glycan Fucosylation and Core Xylosylation in C. reinhardtii journal January 2020
Separation Options for Phosphorylated Osteopontin from Transgenic Microalgae Chlamydomonas reinhardtii journal February 2018
Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. journal August 1996
Neutralizing Anti-IL-10 Antibody Blocks the Protective Effect of Tapeworm Infection in a Murine Model of Chemically Induced Colitis journal May 2005
Infection with a Helminth Parasite Prevents Experimental Colitis via a Macrophage-Mediated Mechanism journal March 2007
Multiple xylosyltransferases heterogeneously xylosylate protein N-linked glycans in Chlamydomonas reinhardtii dataset January 2019